Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pritom Shah is active.

Publication


Featured researches published by Pritom Shah.


Bioorganic & Medicinal Chemistry Letters | 2001

The discovery of a potent, intracellular, orally bioavailable, long duration inhibitor of human neutrophil elastase-GW311616A a development candidate

Simon J. F. Macdonald; Michael Dennis Dowle; Lee Andrew Harrison; Pritom Shah; Martin R. Johnson; Graham G. A. Inglis; Geoffrey D.E Clarke; Robin Smith; Davina Humphreys; Christopher R. Molloy; Augustin Amour; Mary Dixon; Graham Murkitt; Rosalind E. Godward; Tony Padfield; Tadeusz Skarzynski; Onkar M. P. Singh; K.Abhhilash Kumar; Gill Fleetwood; Simon Teanby Hodgson; George W. Hardy; Harry Finch

The discovery of a potent intracellular inhibitor of human neutrophil elastase which is orally active and has a long duration of action is described. The pharmacodynamic and pharmacokinetic properties of a trans-lactam development candidate, GW311616A, are described.


Bioorganic & Medicinal Chemistry Letters | 2001

Intracellular inhibition of human neutrophil elastase by orally active pyrrolidine-trans-lactams

Simon J. F. Macdonald; Michael Dennis Dowle; Lee Andrew Harrison; Julie E. Spooner; Pritom Shah; Martin R. Johnson; Graham G. A. Inglis; Geoffrey D.E Clarke; David J. Belton; Robin Smith; Christopher R. Molloy; Mary Dixon; Graham Murkitt; Rosalind E. Godward; Tadeusz Skarzynski; Onkar M. P. Singh; K.Abhhilash Kumar; Simon Teanby Hodgson; Edward McDonald; George W. Hardy; Harry Finch

Described are the acylation binding of trans-lactam 1 to porcine pancreatic elastase, the selection of the SO2Me activating group for the lactam N which also confers metabolic stability in hamster liver microsomes, the introduction of aqueous solubility through the piperidine salt 9, the in vivo oral activity of 9 and its bioavailability, and the introduction of 9 as an intracellular neutrophil elastase inhibitor.


Bioorganic & Medicinal Chemistry Letters | 2001

Corrigendum to “Intracellular inhibition of human neutrophil elastase by orally active pyrrolidine-trans-lactams”: [Bioorg. Med. Chem. Lett. 11 (2001) 243]

Simon J. F. Macdonald; Michael Dennis Dowle; Lee Andrew Harrison; Julie E. Spooner; Pritom Shah; Martin R. Johnson; Graham G. A. Inglis; Geoffrey D.E Clarke; David J. Belton; Robin Smith; Christopher R. Molloy; Mary Dixon; Graham Murkitt; Rosalind E. Godward; Tadeusz Skarzynski; Onkar M. P. Singh; K.Abhhilash Kumar; Simon Teanby Hodgson; Edward McDonald; George W. Hardy; Harry Finch; Davina Humphreys; Gill Fleetwood

Simon J. F. Macdonald,* Michael D. Dowle, Lee A. Harrison, Julie E. Spooner, Pritom Shah, Martin R. Johnson, Graham G. A. Inglis, Geoffrey D. E. Clarke, David J. Belton, Robin A. Smith, Christopher R. Molloy, Mary Dixon, Graham Murkitt, Rosalind E. Godward, Tadeusz Skarzynski, Onkar M. P. Singh, K. Abhhilash Kumar, Simon T. Hodgson, Edward McDonald, George W. Hardy, Harry Finch, Davina C. Humphreys and Gill Fleetwood


Journal of Medicinal Chemistry | 2002

Discovery of Further Pyrrolidine Trans-Lactams as Inhibitors of Human Neutrophil Elastase (Hne) with Potential as Development Candidates and the Crystal Structure of Hne Complexed with an Inhibitor (Gw475151)

Simon J. F. Macdonald; Michael Dennis Dowle; Lee Andrew Harrison; Geoffrey D. Clarke; Graham G. A. Inglis; Martin R. Johnson; Pritom Shah; Robin Smith; Augustin Amour; Gill Fleetwood; Davina Humphreys; Christopher R. Molloy; Mary Dixon; Rosalind E. Godward; Alan J. Wonacott; Onkar M. P. Singh; Simon Teanby Hodgson; George William Hardy


Archive | 1997

Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Michael Dennis Glaxo Wellcome Plc Dowle; Harry Finch; Lee Andrew Glaxo Wellcome Plc Harrison; Graham George Adam Inglis; Martin Redpath Glaxo Wellcome Plc Johnson; Simon John Fawcett Glaxo Wellcome Plc Macdonald; Pritom Shah; Robin Andrew Glaxo Wellcome Plc Smith


Archive | 1991

C-linked pyrazole derivatives

Barry Clive Ross; David Middlemiss; Colin David Eldred; John Gary Montana; Pritom Shah


Archive | 1991

Benzofuran and benzthiophene derivatives

Barry Clive Ross; David Ian Carter Scopes; Kevin Stuart Cardwell; Colin David Eldred; David Middlemiss; Torquil Iain Maclean Jack; Michael Dennis Dowle; John Gary Montana; Pritom Shah


Archive | 1994

1,5-benzodiazepine derivatives having CCK and/or gastrin antagonistic activity

Harry Finch; Pritom Shah; Robin Arthur Ellis Carr


Archive | 1992

Antihypertensive benzofuran derivatives carrying 4-pyrazolylmethyl substituents

Barry Clive Ross; David Middlemiss; David Ian Carter Scopes; Torquil Iain Maclean Jack; Kevin Stuart Cardwell; Michael Dennis Dowle; Colin David Eldred; John Gary Montana; Pritom Shah; Stephen P. Watson


Archive | 1994

3-PHENYLUREIDO-1,5-BENZODIAZEPINE-DIONES USEFUL AS GASTRIN OR CCK ANTAGONISTS

Harry Finch; David G. Trist; Aldo Feriani; Giorgio Tarzia; Pritom Shah

Collaboration


Dive into the Pritom Shah's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Martin R. Johnson

University of Texas at Austin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David Middlemiss

University of Hertfordshire

View shared research outputs
Top Co-Authors

Avatar

John Gary Montana

University of Hertfordshire

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Harry Finch

Research Triangle Park

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge